Taeyun Kim1, Yunkyung Kim2, Jihun Kang3. 1. Division of Pulmonology, Department of Internal Medicine, The Armed Forces Goyang Hospital, Goyang-si, South Korea. 2. Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea. 3. Department of Family Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea.
Abstract
OBJECTIVES: The present study evaluated the association of electronic cigarette (EC) exposure with serum uric acid (UA) level and hyperuricemia (HUA) using a nationally representative sample of South Korea. METHODS: This study included 10,692 participants (9,905, 609, and 178, never, ever, and current EC users, respectively). Urinary cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels were used to determine conventional smoking exposure among EC users. The association between EC use and UA level was evaluated by linear regression analysis. Multivariable logistic regression analysis was used to assess the association between EC and HUA. Subgroup analysis confined to cotinine-verified active smokers was performed to address the association between the dual use of EC and combustible cigarettes and serum UA levels. RESULTS: The serum UA level was highest among current EC users, followed by ever and never EC users. The prevalence of HUA was 26.2%, 19.3%, and 10.8% in current, ever, and never EC users, respectively. Although EC exposure was positively associated with HUA in a dose-dependent manner only in men (Ptrend = 0.04), a similar tendency was also observed in women with marginal significance (Ptrend = 0.102). The positive association of HUA with EC exposure was more apparent among dual users (odds ratio [OR] = 1.96, 95% confidence interval [CI]: 1.29-2.99) than among those who only smoked combustible cigarettes. CONCLUSIONS: EC exposure was associated with higher serum UA level and higher OR of HUA. The positive association between EC exposure and HUA was more prominent in dual users who concurrently consumed EC and combustible cigarettes.
OBJECTIVES: The present study evaluated the association of electronic cigarette (EC) exposure with serum uric acid (UA) level and hyperuricemia (HUA) using a nationally representative sample of South Korea. METHODS: This study included 10,692 participants (9,905, 609, and 178, never, ever, and current EC users, respectively). Urinary cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels were used to determine conventional smoking exposure among EC users. The association between EC use and UA level was evaluated by linear regression analysis. Multivariable logistic regression analysis was used to assess the association between EC and HUA. Subgroup analysis confined to cotinine-verified active smokers was performed to address the association between the dual use of EC and combustible cigarettes and serum UA levels. RESULTS: The serum UA level was highest among current EC users, followed by ever and never EC users. The prevalence of HUA was 26.2%, 19.3%, and 10.8% in current, ever, and never EC users, respectively. Although EC exposure was positively associated with HUA in a dose-dependent manner only in men (Ptrend = 0.04), a similar tendency was also observed in women with marginal significance (Ptrend = 0.102). The positive association of HUA with EC exposure was more apparent among dual users (odds ratio [OR] = 1.96, 95% confidence interval [CI]: 1.29-2.99) than among those who only smoked combustible cigarettes. CONCLUSIONS: EC exposure was associated with higher serum UA level and higher OR of HUA. The positive association between EC exposure and HUA was more prominent in dual users who concurrently consumed EC and combustible cigarettes.
Authors: Marion Dietrich; Gladys Block; Edward P Norkus; Mark Hudes; Maret G Traber; Carroll E Cross; Lester Packer Journal: Am J Clin Nutr Date: 2003-01 Impact factor: 7.045
Authors: Thomas P Moyer; Joel R Charlson; Robert J Enger; Lowell C Dale; Jon O Ebbert; Darrell R Schroeder; Richard D Hurt Journal: Clin Chem Date: 2002-09 Impact factor: 8.327
Authors: Daniel Owusu; Jidong Huang; Scott R Weaver; Terry F Pechacek; David L Ashley; Pratibha Nayak; Michael P Eriksen Journal: Prev Med Rep Date: 2019-10-25
Authors: Martin Chaumont; Benjamin de Becker; Wael Zaher; Antoine Culié; Guillaume Deprez; Christian Mélot; Florence Reyé; Pierre Van Antwerpen; Cédric Delporte; Nadia Debbas; Karim Zouaoui Boudjeltia; Philippe van de Borne Journal: Sci Rep Date: 2018-07-10 Impact factor: 4.379
Authors: Cria G Perrine; Cassandra M Pickens; Tegan K Boehmer; Brian A King; Christopher M Jones; Carla L DeSisto; Lindsey M Duca; Akaki Lekiachvili; Brandon Kenemer; Mays Shamout; Michael G Landen; Ruth Lynfield; Isaac Ghinai; Amy Heinzerling; Nathaniel Lewis; Ian W Pray; Lauren J Tanz; Anita Patel; Peter A Briss Journal: MMWR Morb Mortal Wkly Rep Date: 2019-10-04 Impact factor: 17.586